Product Pipeline
ENHANZYN™ adjuvant is a composition that we believe activates the human immune system in the context of vaccination. Human clinical data have been published that demonstrate that one of our formulations of ENHANZYN adjuvant may play an important role in generating an immune response with Biomira, Inc.’s line of Theratope® therapeutic cancer vaccines. Biomira has licensed ENHANZYN adjuvant for the clinical development and potential commercialization of Theratope products.

Related News
06/10/1999 Corixa to acquire Ribi
A business overview as well as information on Corixa's partners, management team, employment opportunities, and company contacts.
Corixa's near-term products and adjuvant for research applications.
Product pipeline, therapeutic areas of focus, products, technology platforms, and publications.
Company reports, stockholder letter, events calendar, stock quote, analyst list, and materials request.
Current and archived company press releases.
Product pipeline, therapeutic areas of focus, products, technology platforms, and publications.